다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Clinical and vaccine immunology : CVI, v.20 no.3, 2013년, pp.319 - 327
D'Elia, Riccardo V. (Biomedical Sciences, Dstl Porton Down, Salisbury, United Kingdom) , Harrison, Kate (Biomedical Sciences, Dstl Porton Down, Salisbury, United Kingdom) , Oyston, Petra C. (Biomedical Sciences, Dstl Porton Down, Salisbury, United Kingdom) , Lukaszewski, Roman A. (Biomedical Sciences, Dstl Porton Down, Salisbury, United Kingdom) , Clark, Graeme C. (Biomedical Sciences, Dstl Porton Down, Salisbury, United Kingdom)
AI-Helper
Inflammation is the body's first line of defense against infection or injury, responding to challenges by activating innate and adaptive responses. Microbes have evolved a diverse range of strategies to avoid triggering inflammatory responses. However, some pathogens, such as the influenza virus and...
Eur. Heart J. Kalden 8 1 1987 10.1093/eurheartj/8.suppl_J.1 What is inflammation?
Nature Medzhitov 449 819 2007 10.1038/nature06246 Recognition of microorganisms and activation of the immune response
Anaesth. Intensive Care Lilic 10 218 2009 10.1016/j.mpaic.2009.01.013 Immune response to infection
J. Clin. Invest. Barton 118 413 2008 10.1172/JCI34431 A calculated response: control of inflammation by the innate immune system
Immunity Kato 23 19 2005 10.1016/j.immuni.2005.04.010 Cell type-specific involvement of RIG-I in antiviral response
Nat. Immunol. Yoneyama 5 730 2004 10.1038/ni1087 The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
Immunol. Lett. Heine 139 14 2011 10.1016/j.imlet.2011.04.010 TLRs, NLRs and RLRs: innate sensors and their impact on allergic diseases-a current view
J. Immunol. Couper 180 5771 2008 10.4049/jimmunol.180.9.5771 IL-10: the master regulator of immunity to infection
Nat. Rev. Immunol. Chen 10 826 2010 10.1038/nri2873 Sterile inflammation: sensing and reacting to damage
J. Invest. Surg. Speyer 24 18 2011 10.3109/08941939.2010.521232 Role of endothelial chemokines and their receptors during inflammation
Blood Murdoch 95 3032 2000 10.1182/blood.V95.10.3032 Chemokine receptors and their role in inflammation and infectious diseases
Curr. Opin. Hematol. Zeilhofer 7 178 2000 10.1097/00062752-200005000-00009 Role of interleukin-8 in neutrophil signaling
Nat. Rev. Neurosci. Dantzer 9 46 2008 10.1038/nrn2297 From inflammation to sickness and depression: when the immune system subjugates the brain
Chest Opal 117 1162 2000 10.1378/chest.117.4.1162 Anti-inflammatory cytokines
Mediators Inflamm. Chung 10 51 2001 10.1080/09629350120054518 Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma
Pharmacol. Rev. Asadullah 55 241 2003 10.1124/pr.55.2.4 Interleukin-10 therapy-review of a new approach
Cell Finlay 124 767 2006 10.1016/j.cell.2006.01.034 Anti-immunology: evasion of the host immune system by bacterial and viral pathogens
Mikrobiyol. Bul. Us 42 365 2008 Cytokine storm in avian influenza
Infect. Immun. Mares 76 3001 2008 10.1128/IAI.00215-08 Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns
Crit. Care de Castro 14 115 2010 10.1186/cc8846 First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1
Microbiol. Mol. Biol. Rev. Tisoncik 76 16 2012 10.1128/MMBR.05015-11 Into the eye of the cytokine storm
10.1371/journal.ppat.1000115 PerroneLAPlowdenJKGarcia-SastreAKatzJMTumpeyTM. 2008. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 4:e1000115. doi:10.1371/journal.ppat.1000115.
J. Infect. Dis. Wang 202 991 2010 10.1086/656044 Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza
Respir. Physiol. Neurobiol. Cheng 175 185 2011 10.1016/j.resp.2010.11.004 Three fatal cases of pandemic 2009 influenza A virus infection in Shenzhen are associated with cytokine storm
Microb. Pathog. Sharma 51 39 2011 10.1016/j.micpath.2011.03.007 Features of sepsis caused by pulmonary infection with Francisella tularensis type A strain
Nat. Rev. Microbiol. Oyston 2 967 2004 10.1038/nrmicro1045 Tularaemia: bioterrorism defence renews interest in Francisella tularensis
J. Immunol. Bosio 178 4538 2007 10.4049/jimmunol.178.7.4538 Active suppression of the pulmonary immune response by Francisella tularensis Schu4
Mol. Immunol. Conlan 45 2962 2008 10.1016/j.molimm.2008.01.022 Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis
Br. J. Exp. Pathol. Fleming 10 226 1929 On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae
Annu. Rev. Med. Shenoi 60 307 2009 10.1146/annurev.med.60.053107.103955 Extensively drug-resistant tuberculosis: a new face to an old pathogen
Respirology Udwadia 17 741 2012 10.1111/j.1440-1843.2012.02192.x Totally drug-resistant tuberculosis in India: Who let the djinn out?
Br. J. Pharmacol. Coates 152 1147 2007 10.1038/sj.bjp.0707432 Novel approaches to developing new antibiotics for bacterial infections
Science Fischbach 325 1089 2009 10.1126/science.1176667 Antibiotics for emerging pathogens
Virus Res. Parker 107 165 2005 10.1016/j.virusres.2004.11.006 Metabolism and antiviral activity of ribavirin
Curr. Opin. Infect. Dis. Cameron 14 757 2001 10.1097/00001432-200112000-00015 The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase
J. Virol. Moreno 85 7246 2011 10.1128/JVI.00614-11 Ribavirin can be mutagenic for arenaviruses
Antimicrob. Agents Chemother. Piret 55 459 2011 10.1128/AAC.00615-10 Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management
Trends Biotechnol. Kutateladze 28 591 2010 10.1016/j.tibtech.2010.08.001 Bacteriophages as potential new therapeutics to replace or supplement antibiotics
Emerg. Infect. Dis. Casadevall 2 200 1996 10.3201/eid0203.960306 Antibody-based therapies for emerging infectious diseases
Expert Opin. Ther. Pat. Masihi 13 867 2003 10.1517/13543776.13.6.867 Progress on novel immunomodulatory agents for HIV-1 infection and other infectious diseases
Drugs Foster 70 147 2010 10.2165/11531990-000000000-00000 Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b
Br. J. Clin. Pharmacol. Khakoo 46 563 1998 10.1046/j.1365-2125.1998.00836.x Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions
J. Immunol. Elkins 162 2291 1999 10.4049/jimmunol.162.4.2291 Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria
Infect. Immun. Waag 74 1944 2006 10.1128/IAI.74.3.1944-1948.2006 A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei
Infect. Immun. Wongratanacheewin 72 4494 2004 10.1128/IAI.72.8.4494-4502.2004 Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei
10.1186/1476-8518-8-2 RozakDAGelhausHCSmithMZadehMHuzellaLWaagDAdamoviczJJ. 2010. CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols. J. Immune Based Ther. Vaccines 8:2. doi:10.1186/1476-8518-8-2.
J. Cell. Biochem. Dinarello 39 229 1989 10.1002/jcb.240390303 Role for interleukin-1 in the pathogenesis of hypersensitivity diseases
Surgery Michie 104 280 1988 Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings
Blood Crown 78 1420 1991 10.1182/blood.V78.6.1420.1420 A phase I trial of recombinant human interleukin-1-beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer
Shock Song 30 468 2008 10.1097/SHK.0b013e31816d5e49 The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats
Clin. Exp. Immunol. Yoshikawa 146 116 2006 10.1111/j.1365-2249.2006.03169.x Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappa B phosphorylation and nuclear factor-kappa B transcriptional activity through nicotinic acetylcholine receptor alpha 7
Nature Borovikova 405 458 2000 10.1038/35013070 Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
J. Thromb. Haemost. Van Westerloo 4 1997 2006 10.1111/j.1538-7836.2006.02112.x Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats
J. Immunol. Matsunaga 167 6518 2001 10.4049/jimmunol.167.11.6518 Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine
Int. Immunopharmacol. Mamata 5 749 2005 10.1016/j.intimp.2004.12.010 Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells
Behav. Brain Res. Kem 113 169 2000 10.1016/S0166-4328(00)00211-4 The brain alpha 7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21)
Psychopharmacology Martin 174 54 2004 10.1007/s00213-003-1750-1 Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
Am. J. Psychiatry Freedman 165 1040 2008 10.1176/appi.ajp.2008.07071135 Initial phase 2 trial of a nicotinic agonist in schizophrenia
Crit. Care Med. Pavlov 35 1139 2007 10.1097/01.CCM.0000259381.56526.96 Selective alpha 7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis
Biochem. Pharmacol. Kox 78 863 2009 10.1016/j.bcp.2009.06.096 GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation
Shock Kox 36 5 2011 10.1097/SHK.0b013e3182168d56 Effects of the alpha 7 nicotinic acetylcholine receptor agonist Gts-21 on the innate immune response in humans
J. Endotoxin Res. Villa 4 197 1997 10.1177/096805199700400305 Protection against lethal polymicrobial sepsis by CNI-1493, an inhibitor of pro-inflammatory cytokine synthesis
J. Microencapsul. Oettinger 27 372 2010 10.3109/02652040903243437 Synergism in survival to endotoxic shock in rats given microencapsulated CNI-1493 and antisense oligomers to NF-kappa B
Curr. Opin. Infect. Dis. Yoshikai 14 257 2001 10.1097/00001432-200106000-00003 Roles of prostaglandins and leukotrienes in acute inflammation caused by bacterial infection
Shock Strong 14 374 2000 10.1097/00024382-200014030-00023 Blocking prostaglandin E-2 after trauma attenuates pro-inflammatory cytokines and improves survival
10.1371/journal.pone.0011610 CareyMABradburyJARebollosoYDGravesJPZeldinDCGermolecDR. 2010. Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice. PLoS One 5:e11610. doi:10.1371/journal.pone.0011610.
J. Infect. Dis. Lee 198 525 2008 10.1086/590499 Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection
Thorax Lauder 66 368 2011 10.1136/thx.2010.150318 Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity
Proc. Natl. Acad. Sci. U. S. A. Zheng 105 8091 2008 10.1073/pnas.0711942105 Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus
Discov. Med. Garcia 10 479 2010 The development of anti-inflammatory drugs for infectious diseases
Crit. Care Med. Zimmerman 30 S294 2002 10.1097/00003246-200205001-00020 The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis
Biochimie Yost 92 692 2010 10.1016/j.biochi.2010.02.011 The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses
Shock Gomes 26 41 2006 10.1097/01.shk.0000209562.00070.1a Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis
Crit. Care Med. Schuster 31 1612 2003 10.1097/01.CCM.0000063267.79824.DB Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: phase IIb, multicenter, randomized, placebo-controlled, clinical trial
Crit. Care Med. Opal 32 332 2004 10.1097/01.CCM.0000108867.87890.6D Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial
Proc. Natl. Acad. Sci. U. S. A. Souza 106 14138 2009 10.1073/pnas.0906467106 Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection
Annu. Rev. Pharmacol. Toxicol. Fernandez 42 469 2002 10.1146/annurev.pharmtox.42.091901.115838 Structure junction, and inhibition of chemokines
J. Intern. Med. Baggiolini 250 91 2001 10.1046/j.1365-2796.2001.00867.x Chemokines in pathology and medicine
Biochem. Pharmacol. Ajuebor 63 1191 2002 10.1016/S0006-2952(02)00854-7 Chemokines as novel therapeutic targets in inflammatory diseases
Infect. Immun. Nakano 62 377 1994 10.1128/IAI.62.2.377-383.1994 Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor
J. Leukoc. Biol. Strieter 57 752 1995 10.1002/jlb.57.5.752 Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
J. Immunol. Laning 153 4625 1994 10.4049/jimmunol.153.10.4625 Inhibition of in vivo tumor growth by the beta chemokine, TCA3
Nat. Med. Premack 2 1174 1996 10.1038/nm1196-1174 Chemokine receptors: gateways to inflammation and infection
Genome Biol. Zlotnik 7 243 2006 10.1186/gb-2006-7-12-243 The chemokine and chemokine receptor superfamilies and their molecular evolution
Eur. J. Immunol. Tran 30 1410 2000 10.1002/(SICI)1521-4141(200005)30:5<1410::AID-IMMU1410>3.0.CO;2-L Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor
Methods Karpus 29 362 2003 10.1016/S1046-2023(02)00360-2 Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease
J. Immunol. Lin 186 508 2011 10.4049/jimmunol.1001002 CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection
Immunology Reckless 103 244 2001 10.1046/j.1365-2567.2001.01228.x The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo
Nat. Med. O'Garra 10 801 2004 10.1038/nm0804-801 Regulatory T cells and mechanisms of immune system control
Nat. Rev. Immunol. Bluestone 3 253 2003 10.1038/nri1032 Natural versus adaptive regulatory T cells
Immunol. Rev. Shevach 212 60 2006 10.1111/j.0105-2896.2006.00415.x The lifestyle of naturally occurring CD4(+)CD25(+)Foxp3(+) regulatory T cells
Blood Deaglio 109 5390 2007 10.1182/blood-2006-12-061812 CD38/CD19: a lipid raft-dependent signaling complex in human B cells
Nat. Immunol. Fontenot 4 330 2003 10.1038/ni904 Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells
J. Exp. Med. Fontenot 202 901 2005 10.1084/jem.20050784 Developmental regulation of Foxp3 expression during ontogeny
J. Clin. Invest. Chatila 106 R75 2000 10.1172/JCI11679 JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome
Nat. Genet. Bennett 27 20 2001 10.1038/83713 The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
Curr. Opin. Pediatr. Bennett 13 533 2001 10.1097/00008480-200112000-00007 IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena
Science Hori 299 1057 2003 10.1126/science.1079490 Control of regulatory T cell development by the transcription factor Foxp3
J. Allergy Clin. Immunol. Akdis 116 961 2005 10.1016/j.jaci.2005.09.004 T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases
Immunology Taams 118 1 2006 10.1111/j.1365-2567.2006.02348.x Regulatory T cells in human disease and their potential for therapeutic manipulation
Immunol. Rev. Brusko 223 371 2008 10.1111/j.1600-065X.2008.00637.x Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
J. Exp. Med. Serhan 192 1197 2000 10.1084/jem.192.8.1197 Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing
Nature Schwab 447 869 2007 10.1038/nature05877 Resolvin E1 and protectin D1 activate inflammation-resolution programmes
J. Exp. Med. Serhan 196 1025 2002 10.1084/jem.20020760 Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals
J. Immunol. Bannenberg 174 4345 2005 10.4049/jimmunol.174.7.4345 Molecular circuits of resolution: formation and actions of resolvins and protectins
J. Biol. Chem. Sun 282 9323 2007 10.1074/jbc.M609212200 Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation
Proc. Natl. Acad. Sci. U. S. A. Arita 102 7671 2005 10.1073/pnas.0409271102 Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis
J. Immunol. Duffield 177 5902 2006 10.4049/jimmunol.177.9.5902 Resolvin D series and protectin D1 mitigate acute kidney injury
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.